- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 15, 2024 | 114.35M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $25.69K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $29.39K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $372.46K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $413.61K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $372.46K |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $413.61K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $95.98K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $179.91K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $101.04K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $185.62K |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 92.52M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$69.76K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $38.6K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $32K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $116K |
| Revenue | Q1 2024 · Mar 31, 2023 | $148K |